News › Clinical Practice, Industry News

Pulse Biosciences Announces Presentation of Clinical Results Using Nano-Pulse Stimulation Technology

October 8, 2020

Pulse Biosciences, Inc., a bioelectric medicine company progressing Nano-Pulse Stimulation (NPS) technology, has announced that clinical results from studies spanning the company’s dermatologic application portfolio will be presented at the American Society for Dermatologic Surgery (ASDS) virtual annual meeting on October 9 – 11, 2020. Positive study results generated using the company’s cellular-specific NPS mechanism performed with its CellFX System for the treatment of sebaceous hyperplasia lesions, cutaneous non-genital warts, plantar warts and basal cell carcinoma will be presented in two oral presentations and two e-posters.
Read more at Business Wire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • South Carolina Medical Board Warns Against Use of Research-Grade Peptides
    • Lilly Sues Six Companies Over Alleged Sales of Experimental Weight-Loss Drug Retatrutide
    • DaySpark Becomes Silver Vendor Affiliate with the American Med Spa Association
    • Allergan Aesthetics Refreshes Allergan Partner Privileges to Better Support Today’s Modern Aesthetics Practices
    • Galderma Receives EU Approval for Restylane Shaype: Bone-Mimicking Hyaluronic Acid Injectable for Chin
Advertisement